Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 4 relevant journals, 30 Conferences/workshops, 8 Symposium are presently dedicated exclusively to herpes simplex virus (HSV) and about 11 articles are being published on herpes simplex virus (HSV).
The herpes simplex virus, also known as HSV, is an infection that causes herpes. The herpes simplex virus, or herpes, is categorized into two types: herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2).
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
The herpes simplex virus is a contagious virus that can be passed from person to person through direct contact. Infection with the herpes simplex virus, commonly known as herpes, can be due to either herpes simplex virus 1 (HSV-1) or herpes simplex virus 2 (HSV-2). HSV-1 is mainly transmitted by oral to oral contact. HSV-2 is a sexually transmitted infection that can cause painful genital ulcer disease.
HSV-1 is a highly contagious infection, which is common and endemic throughout the world. The virus causes lifelong infection, and there is no cure, although treatment can reduce symptoms. In people with weak immune systems, such as those with advanced HIV infection, HSV-1 can have more severe symptoms and more frequent recurrences. HSV-1 in a person with advanced HIV disease can also lead to more serious, but rare, complications such as dissemination, encephalitis, or ocular disease.
HSV-2 infection is widespread and mainly sexually transmitted. Infection with HSV-2 is life-long, and there is no cure. It is estimated that up to 20 million people are newly infected with HSV-2 each year. HSV-2 infection occurs worldwide and is a major global health problem. HSV-2 is amongst the most common infections in people living with HIV, occurring in 60-90% of HIV-infected persons. HSV-2 infection increases the risk of acquiring a new HIV infection by approximately three-fold. In addition, people with both HIV and HSV-2 infection are more likely to spread HIV to others.
Antivirals, such as acyclovir, famciclovir, and valacyclovir are the most effective medications available for people infected with HSV. These can help to reduce the severity and frequency of symptoms, but they cannot cure the infection.
Globally, an estimated 4.0 billion people are infected with Herpes Virus. About 79% of the US population is infected with HSV1, with about 25-35% of the adults enduring recurrent spate of cold sores. Meanwhile, Genital herpes, caused by HSV-2, is one of the most common sexually transmitted diseases in the US. The US represents the largest regional market for Herpes Simplex Virus treatment worldwide. However, growth in the market would be led by US, which is projected to be the fastest growing regional market during the analysis period. The Cold Sore Medication Manufacturing industry is highly concentrated. GlaxoSmithKline and Novartis AG, the industry's two largest companies, are expected to generate 47.3% of total industry revenue in 2015. Rest of World is projected to post a compounded annual growth rate of close to 6.9%.
International Conferences
Major Associations and Societies
This page will be updated regularly.
This page was last updated on April 20, 2024